GlaxoSmithKline

NYSE
GSK
Stock
Yield per half year: +10.33%
Dividend yield: 4.17%
Sector: Healthcare

GlaxoSmithKline

45.0045.0042.0042.0039.0039.0036.0036.0033.0033.0030.0030.00Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
21.56 29.26 -26.32% 12.8 +68.48%
P/S 1.77 3.99 -55.68%
P/BV 4.24 10.48 -59.53%
P/FCF 22.16 37.19 -40.41%
Ev/Ebitda 10.32 18.36 -43.79%
Ev/S 2.19 4.31 -49.16%
Ev/FCF 19.26 46.13 -58.24%
E/P 0.0325 0.1739 -81.31%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
21.25 21.35 -0.4806% 25.54 -16.8%
ROE 19.06 -73.65 -125.88%
ROA 4.35 6.71 -35.22%
ROIC 12.84 21.56 -40.43%
ROS 8.21 10.72 -23.4%
ROCE 31.46 83.58 -62.36%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
5/10
2.55 2.73 -6.7% 2.45 +3.91%
Nеt Debt/Ebitda 1.99 2.87 -30.54%
Debt/Ratio 0.2857 0.2923 -2.27%
Debt/Equity 3.54 14.95 -76.29%
Debt/Net Income 6.6 5.02 31.38%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
4.17 1.3 221.59% 4.71 -11.48%
Number of years of dividend growth 1 6.36 -84.27%
DSI 0.7143 0.7363 -2.99%
Average dividend growth -2.24 -7.81 -71.37%
Average percentage for 5 years 4.71 1.29 265.41%
Average percentage for payments 97.89 42.3 131.43%
Difference from average difference in sector 2.87

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-7.99 1169.02 -100.68%
Growth impulse Ebitda in 5 years -21.4 151.11 -114.16%
Growth impulse Net Income in 5 years -55.21 10125.27 -100.55%
Growth impulse FCF in 5 years -42.41 5781.14 -100.73%
Growth impulse EPS in 5 years -67.19 13603.5 -100.49%
IP Score
4.86/10

Similar companies

Bristol-Myers

Humana

UnitedHealth Group

Johnson & Johnson

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription